Table 3.
Relapses and deaths in paediatric patients with ALL who were younger than 16 years of age and who were treated at the paediatric haematology service of the specialist “La Raza” IMSS Medical Centre.
| N = 302 | Total | Relapse (at 3 years) |
Not Relapse (at 3 years) |
Relapse (at 5 year) |
No Relapse (at 5 years) |
Death (at 3 years) |
Lives (at 3 years) |
Death (at 5 years) |
Lives (at 5 years) |
|---|---|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Sex | |||||||||
| Male (%) | 167 (100) | 41 (24.6) | 126 (75.4) | 51 (30.5) | 116 (69.5) | 48 (28.7) | 119 (71.3) | 54 (32.3) | 113 (67.7) |
| Female (%) | 135 (100) | 26 (19.3) | 109 (80.7) | 28 (20.7) | 107 (79.3) | 44 (32.6) | 91 (67.4) | 52 (38.5) | 83 (61.5) |
| Age (years) | |||||||||
| <1 | 1 (100) | 1 (100) | 0 (0.0) | 1 (100) | 0 (0.0) | 0 (0) | 1 (100) | 1 (100) | 0 (0.0) |
| 1–5 | 122 (100) | 25 (20.5) | 97 (79.5) | 31 (25.4) | 91 (74.0) | 29 (23.8) | 93 (76.2) | 35 (28.7) | 87 (71.3) |
| 5.1–9.99 | 66 (100) | 17 (25.8) | 49 (74.2) | 19 (28.8) | 47 (71.2) | 22 (33.3) | 44 (66.7) | 26 (39.4) | 40 (60.6) |
| ≥10 | 113 (100) | 24 (21.2) | 89 (78.7) | 28 (24.8) | 85 (75.2) | 41 (36.3) | 72 (63.7) | 44 (38.9) | 69 (61.1) |
| Lineage | |||||||||
| B | 279 (100) | 73 (22.6) | 216 (77.4) | 75 (26.9) | 204 (73.1) | 81 (29.0) | 198 (71.0) | 94 (33.7) | 185 (66.3) |
| T | 23 (100) | 4 (17.4) | 19 (82.6) | 4 (17.9) | 19 (82.6) | 11 (47.8) | 12 (52.2) | 12 (52.2) | 11 (47.8) |
| Risk group | |||||||||
| Standard | 146 (100) | 37 (25.3) | 109 (74.7) | 44 (30.1) | 102 (69.9) | 44 (30.1) | 102 (69.9) | 48 (32.9) | 98 (67.1) |
| High | 156 (100) | 30 (19.2) | 126 (80.8) | 35 (22.4) | 121 (77.6) | 48 (30.8) | 108 (69.2) | 58 (37.2) | 98 (62.8) |
| WBC (1 × 109/L) | |||||||||
| <10 | 147 (100) | 34 (23.1) | 113 (76.9) | 38 (25.9) | 109 (74.1) | 40 (27.2) | 107 (72.8) | 43 (29.3) | 104 (70.7) |
| 10–20 | 48 (100) | 10 (20.8) | 38 (79.2) | 14 (29.2) | 34 (70.8) | 18 (37.5) | 30 (62.5) | 20 (41.7) | 28 (58.3) |
| 20–50 | 34 (100) | 3 (8.8) | 31 (91.2) | 5 (14.7) | 29 (85.3) | 11 (32.4) | 23 (67.6) | 12 (35.3) | 22 (64.7) |
| 50–100 000 | 27 (100) | 7 (25.9) | 20 (74.1) | 8 (29.6) | 19 (70.4) | 6 (22.2) | 21 (77.8) | 10 (37.0) | 17 (63.0) |
| ≥100 | 46 (100) | 13 (28.3) | 33 (71.7) | 14 (30.4) | 32 (69.6) | 17 (37.0) | 29 (63.0) | 21 (45.7) | 26 (54.3) |